Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 03:33PM EDT. Market open.
| Previous close | 232.56 |
| Open | 237.83 |
| Bid | 239.23 x 900 |
| Ask | 239.52 x 800 |
| Day's range | 236.22 - 242.85 |
| 52-week range | 161.65 - 275.00 |
| Volume | |
| Avg. volume | 531,750 |
| Market cap | 12.327B |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | 25.98 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
WILMINGTON, Mass., April 22, 2024--In addition to advancing human health and improving quality of life, we are dedicated to a responsible tomorrow.
- Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
WILMINGTON, Mass., April 16, 2024--Charles River launches the Alternative Methods Advancement Project (AMAP), an initiative to develop alternatives to reduce animal testing.
- Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
WILMINGTON, Mass., April 12, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9th, before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9th, at 8:30 a.m. ET.
© 2024 Yahoo. All rights reserved.